Liu X, Yin X, Zhuang L, Wen J, et al. Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study. BMC Cancer 2025;25:509.
PMID: 40114144